相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice
Jian Guo et al.
CARDIOVASCULAR RESEARCH (2009)
Cathepsin K: boon or bale for atherosclerotic plaque stability?
Oliver Hofnagel et al.
CARDIOVASCULAR RESEARCH (2009)
Cathepsin K inhibitors as treatment of bone metastasis
Céline Le Gall et al.
Current Opinion in Supportive and Palliative Care (2009)
Relation of bone mineral density to frequency of coronary heart disease
Raja Varma et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Role of inflammation in atherosclerosis associated with rheumatoid arthritis
Peter Libby
AMERICAN JOURNAL OF MEDICINE (2008)
Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice
Andriy O. Samokhin et al.
ATHEROSCLEROSIS (2008)
Biochemical properties and regulation of cathepsin K activity
Fabien Lecaille et al.
BIOCHIMIE (2008)
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
Jacques Yves Gauthier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Risks and benefits of bisphosphonates
R. E. Coleman
BRITISH JOURNAL OF CANCER (2008)
Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression
Celina G. Kleer et al.
CLINICAL CANCER RESEARCH (2008)
Statins: under investigation for increasing bone mineral density and augmenting fracture healing
Quen Oak Tang et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Proteolytic processing of chemokines: Implications in physiological and pathological conditions
Marlene Wolf et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Cathepsin K in melanoma invasion
Maria J. Quintanilla-Dieck et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Identification of a Nonbasic, Nitrile-Containing Cathepsin K Inhibitor (MK-1256) that is Efficacious in a Monkey Model of Osteoporosis
Joel Robichaud et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The Crystal and Molecular Structures of a Cathepsin K:Chondroitin Sulfate Complex
Zhenqiang Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Recent advances in pharmacological management of osteoporosis
Atsushi Suzuki et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
The Transcription Factor ETS-1: Its Role in Tumour Development and Strategies for its Inhibition
Jens Claus Hahne et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis
Masataka Asagiri et al.
SCIENCE (2008)
Cysteine cathepsin proteases as pharmacological targets in cancer
Carmela Palermo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Osteoclast targeted therapy for prostate cancer: Bisphosphonates and beyond
Matthew R. Smith
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Combination anabolic and antiresorptive therapy for osteoporosis: Opening the anabolic window
John P. Bilezikian
Current Osteoporosis Reports (2008)
The imbalance between osteoprotegerin and cathepsin K in the serum of patients with longstanding rheumatoid arthritis
Martin Skoumal et al.
RHEUMATOLOGY INTERNATIONAL (2008)
Effect of cathepsin K inhibitor basicity on in vivo off-target activities
Sylvie Desmarais et al.
MOLECULAR PHARMACOLOGY (2008)
Cathepsin K inhibitors: A novel target for osteoporosis therapy
S. A. Stoch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: A double-blind, placebo-controlled, dose-ranging trial
Henry G. Bone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
A cathepsin K inhibitor reduces breast cancer-induced osteolysis and skeletal tumor burden
Celine Le Gall et al.
CANCER RESEARCH (2007)
Cathepsin cysteine proteases in cardiovascular disease
Suzanne P. M. Lutgens et al.
FASEB JOURNAL (2007)
Cathepsin K in the bone microenvironment: link between obesity and prostate cancer?
I. Podgorski et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Cathepsin K Null Mice Show Reduced Adiposity during the Rapid Accumulation of Fat Stores
Marcella Funicello et al.
PLOS ONE (2007)
Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis
Manu O. Platt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Role of cathepsin K in normal joints and in the development of arthritis
H. J. Salminen-Mankonen et al.
CURRENT DRUG TARGETS (2007)
A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys
S. Kumar et al.
BONE (2007)
Effects of statins on bone mineral density: A meta-analysis of clinical studies
Bernard Uzzan et al.
BONE (2007)
Emerging pharmacologic therapies for osteoporosis
Andrew Grey
EXPERT OPINION ON EMERGING DRUGS (2007)
Chemokines in oral inflammatory diseases: Apical periodontitis and periodontal disease
T. A. Silva et al.
JOURNAL OF DENTAL RESEARCH (2007)
Gene profiling of cathepsin K deficiency in atherogenesis: profibrotic but lipogenic
S. P. M. Lutgens et al.
JOURNAL OF PATHOLOGY (2006)
The consequences of lysosomotropism on the design of selective cathepsin K inhibitors
W. Cameron Black et al.
CHEMBIOCHEM (2006)
Cysteine cathepsins: multifunctional enzymes in cancer
Mona Mostafa Mohamed et al.
NATURE REVIEWS CANCER (2006)
Fracture incidence and characterization in patients on osteoporosis treatment: The ICARO study
Silvano Adami et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins
Martin Linke et al.
BIOLOGICAL CHEMISTRY (2006)
Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways
Yusuke Shinoda et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis
Murray C. H. Clarke et al.
NATURE MEDICINE (2006)
Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metal loproteinase-12 in non-small cell lung cancer
Heath B. Acuff et al.
CANCER RESEARCH (2006)
Adiponectin: a link between obesity and cancer
Diana Barb et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma - A useful marker of invasive growth
Ida Rapa et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells
Orit Kollet et al.
NATURE MEDICINE (2006)
The molecular mechanism of nitrogen-containing bisphosphonates as anti osteoporosis drugs
Kathryn L. Kavanagh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification of a potent and selective non-basic cathepsin K inhibitor
CS Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Degraded collagen induces calpain-mediated apoptosis and destruction of the X-chromosome-linked inhibitor of apoptosis (xIAP) in human vascular smooth muscle cells
KV Lipinski et al.
CARDIOVASCULAR RESEARCH (2006)
Structural basis for the exceptional in vivo efficacy of bisphosphonate drugs
Jean-Michel Rondeau et al.
CHEMMEDCHEM (2006)
Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis
J Condeelis et al.
CELL (2006)
Disruption of the Cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation
E Lutgens et al.
CIRCULATION (2006)
Stromal-epithelial interaction in prostate cancer progression
Leland W. K. Chung et al.
CLINICAL GENITOURINARY CANCER (2006)
Mechanisms of disease: is osteoporosis the obesity of bone?
CJ Rosen et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
The relative merits of anabolics versus anti-resorptive compounds: where our targets should be, and whether we are addressing them
Jurg A. Gasser
CURRENT OPINION IN PHARMACOLOGY (2006)
Targeting proteases: successes, failures and future prospects
Boris Turk
NATURE REVIEWS DRUG DISCOVERY (2006)
Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity
JP Falgueyret et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
ETS transcription factors and their emerging roles in human cancer
A Seth et al.
EUROPEAN JOURNAL OF CANCER (2005)
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis
DM Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies
D Hamerman
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2005)
The role of cathepsins in osteoporosis and arthritis:: Rationale for the design of new therapeutics
Y Yasuda et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice
E Bengtsson et al.
ATHEROSCLEROSIS (2005)
Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: Role of cAMP-dependent protein kinase a signaling pathway
WC Huang et al.
CANCER RESEARCH (2005)
Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer
I Podgorski et al.
NEOPLASIA (2005)
Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction
M Skoumal et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Regulation of collagenase activities of human cathepsins by glycosaminoglycans
ZQ Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Lysosomal cysteine proteases in atherosclerosis
JA Liu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells
JP Falgueyret et al.
ANALYTICAL BIOCHEMISTRY (2004)
Cathepsin K:: a cysteine protease with unique kinin-degrading properties
E Godat et al.
BIOCHEMICAL JOURNAL (2004)
Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women
L Rejnmark et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Cathepsin K mRNA and protein expression in prostate cancer progression
KD Brubaker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Disruption of adiponectin causes insulin resistance and neointimal formation.
N Kubota et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cardiovascular disease and osteoporosis: is there a link between lipids and bone?
JR Burnett et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2002)
Plasma lipids and osteoporosis in postmenopausal women
T Yamaguchi et al.
ENDOCRINE JOURNAL (2002)
RANK ligand and osteoprotegerin - Paracrine regulators of bone metabolism and vascular function
M Schoppet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation
CS Hsieh et al.
JOURNAL OF IMMUNOLOGY (2002)
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques
CR Dhore et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate
GB Stroup et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Acid attack and cathepsin K in bone resorption around total hip replacement prosthesis
YT Konttinen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Azepanone-based inhibitors of human and rat cathepsin K
RW Marquis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages
GP Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Modified LDL-trigger of atherosclerosis and inflammation in the arterial intima
MO Pentikainen et al.
JOURNAL OF INTERNAL MEDICINE (2000)
分享论文
